Strong antibody responses induced by protein antigens conjugated onto the surface of lecithin-based nanoparticles
about
Relationship between the size of nanoparticles and their adjuvant activity: data from a study with an improved experimental designProtein coated microcrystals formulated with model antigens and modified with calcium phosphate exhibit enhanced phagocytosis and immunogenicity.Towards preserving the immunogenicity of protein antigens carried by nanoparticles while avoiding the cold chain.Tresyl-based conjugation of protein antigen to lipid nanoparticles increases antigen immunogenicity.A polymer/oil based nanovaccine as a single-dose immunization approach.Theranostic nanoparticles carrying doxorubicin attenuate targeting ligand specific antibody responses following systemic delivery.In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticles.Permeation of antigen protein-conjugated nanoparticles and live bacteria through microneedle-treated mouse skin.Negatively charged liposomes show potent adjuvant activity when simply admixed with protein antigensA method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitution.EGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activityLipid nanocapsule as vaccine carriers for his-tagged proteins: evaluation of antigen-specific immune responses to HIV I His-Gag p41 and systemic inflammatory responsesSynthesis and in vitro evaluation of novel lipophilic monophosphorylated gemcitabine derivatives and their nanoparticles.The Carbomer-Lecithin Adjuvant Adjuplex Has Potent Immunoactivating Properties and Elicits Protective Adaptive Immunity against Influenza Virus Challenge in Mice.Acetalated Dextran Microparticulate Vaccine Formulated via Coaxial Electrospray Preserves Toxin Neutralization and Enhances Murine Survival Following Inhalational Bacillus Anthracis Exposure.Microneedle-mediated transcutaneous immunization with plasmid DNA coated on cationic PLGA nanoparticlesEvaluation of Immunoprotection Conferred by the Subunit Vaccines of GRA2 and GRA5 against Acute Toxoplasmosis in BALB/c Mice.Applications of nanomaterials as vaccine adjuvants.Engineered Human Ferritin Nanoparticles for Direct Delivery of Tumor Antigens to Lymph Node and Cancer Immunotherapy.Aluminum hydroxide nanoparticles show a stronger vaccine adjuvant activity than traditional aluminum hydroxide microparticlesNano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses.Carrier mediated protein and peptide stabilization.Challenges in development of nanoparticle-based therapeutics.Bovine serum albumin adsorbed PGA-co-PDL nanocarriers for vaccine delivery via dry powder inhalation.Antigen-conjugated N-trimethylaminoethylmethacrylate chitosan nanoparticles induce strong immune responses after nasal administration.Rationalization of a nanoparticle-based nicotine nanovaccine as an effective next-generation nicotine vaccine: A focus on hapten localization.The immunogenicity of thin-film freeze-dried, aluminum salt-adjuvanted vaccine when exposed to different temperatures.Aluminum (Oxy)Hydroxide Nanosticks Synthesized in Bicontinuous Reverse Microemulsion Have Potent Vaccine Adjuvant Activity.Pre-clinical assessment of the effectiveness of modified polyvalent antivenom in the neutralization of Naja naja venom toxicity.
P2860
Q33779670-E4591DF1-559D-4D5E-9092-D10FCC8A2D73Q33912121-E5BEEC77-4CA7-4A57-89FA-248FD4E86D27Q33946847-69EE270F-574E-4A05-A968-957476D05DB2Q34258873-7F0CCAF9-464E-4358-8B39-C998C141E69FQ34685874-5655CA5C-E8D4-491D-8B22-88BCDB47008BQ34698633-E68636EF-816D-4CC5-9A64-495C04E8A596Q34819537-E4E14779-6421-459E-962C-7CEDAFD29D1EQ35090493-2DD3B208-1FF5-4112-9451-32EB8EB4E25AQ35141341-1CB5FDB0-4E2B-4405-A1E1-F15A39792AF6Q35268788-EC40D697-5B3B-4485-975E-12190CB50C3AQ35659449-AF4B27E8-458E-4A29-9E9F-B7C49F4A5063Q35740218-66865E10-95E0-444C-A269-E9AF9854AB87Q35909171-6805DE6D-CFD9-4663-B7F1-B0106CB4DD2DQ35998757-DC84B070-B1D0-48D2-B94A-7745D759E730Q36122915-A03F1014-EBA6-482E-BCE9-5F49CE8B7A30Q36339297-A0E8D3B1-DC96-463E-BEDE-BB04C8CB8630Q36843269-C401CE06-D718-408A-A959-14C5C023EEF4Q37159697-FEC970BA-E985-4136-9178-2354F71D9DFFQ37325317-03595BB0-C6EE-4737-9C8B-3BC03F4167BAQ37571922-13CF3AED-CA84-47FE-9E70-A13752B7FC55Q37785952-2942F842-C38B-43AF-A373-7A5716394267Q37794158-C2F1FEA8-CCDF-488A-A0F6-64B24042D131Q37992525-710CFC1D-93B2-4057-B882-0F490B491367Q38949613-006EC96E-1CBB-453E-834D-673D32B828BDQ38980665-0F31FC93-E36E-4242-8AF5-4447126A9C83Q45060078-9B86ED29-2514-427C-BE0C-37682580E31CQ47121608-B2B1D86F-8E4B-4983-A413-A1430FF45A9CQ48265935-A27D0FCA-E6C6-4CC9-9EA2-1BB8A9E8D6FEQ53369257-33B3CE06-A1B2-49BF-828A-C7ACAEE8ADEE
P2860
Strong antibody responses induced by protein antigens conjugated onto the surface of lecithin-based nanoparticles
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Strong antibody responses indu ...... f lecithin-based nanoparticles
@en
Strong antibody responses indu ...... lecithin-based nanoparticles.
@nl
type
label
Strong antibody responses indu ...... f lecithin-based nanoparticles
@en
Strong antibody responses indu ...... lecithin-based nanoparticles.
@nl
prefLabel
Strong antibody responses indu ...... f lecithin-based nanoparticles
@en
Strong antibody responses indu ...... lecithin-based nanoparticles.
@nl
P2093
P2860
P1476
Strong antibody responses indu ...... f lecithin-based nanoparticles
@en
P2093
Andrew M Hau
Brian R Sloat
Michael A Sandoval
Zhengrong Cui
P2860
P304
P356
10.1016/J.JCONREL.2009.08.023
P407
P50
P577
2009-09-01T00:00:00Z